DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20212674

Effectiveness of structured teaching programme regarding polycystic ovarian syndrome among adolescent girls

Soniya John

Abstract


Background: Polycystic ovary syndrome is an endocrine disorder that affects approximately 5% of all women. It occurs amongst all races and nationalities. It is the most common hormonal disorder among women of reproductive age and is a leading cause of infertility. As polycystic ovarian syndrome is an ovarian disorder marked by a lack of estrogen, hyperandrogenaemia, obesity, hyper insulinaemia and starts early in the adolescent period. So, we should teach them regarding the clinical features treatment and prevention.

Methods: A quasi experimental one group pre-test post design was adopted to assess the effectiveness of structured teaching programme on knowledge regarding polycystic ovarian syndrome among adolescent girls, Bangalore. A sample of 60 adolescent girls was selected from NRI higher secondary school, Bangalore by purposive sampling technique. Collected data was analysed by using descriptive and inferential statistics.

Results: More than half 54 (90.0%) were having inadequate knowledge and 6 (10%) were having moderate knowledge regarding PCOS before STP.

Conclusions: Structured teaching programme was significantly effective in increasing the knowledge of polycystic ovarian syndrome. The most important role of the nurse is to provide awareness on prevention and health promotion.

 


Keywords


Adolescent girls, Structured teaching programme, PCOS

Full Text:

PDF

References


Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279-86.

Christine CR, Didier D. Diagnosis of Hyperandrogenism in Female Adolescents, 2006. Available at: http://www.health.am/gyneco/more/diagnosisofhyperandrogenism-in-female/. Accessed on 1 May 2021.

Cocksedge KA, Li TC, Saravelos SH, Metwally M. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online. 2008;17(1):151-60.

Pillittire A. Maternal and child health nursing. 6th ed. Lippincott Publishers; 2009: 916.

Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab. 2006;91(3):781-5.

Carmina E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecol. 2004;56(1):1-6.

Pedersen SD, Brar S, Faris P, Corenblum B. Polycystic ovary syndrome: validated questionnaire for use in diagnosis. Can Fam Physician. 2007;53(6):1042-7.

Somani N, Harrison S, Bergfeld WF. The clinical evaluation of hirsutism. Dermatol Ther. 2008;21(5):376-91.

Sharquie KE, Bayatti AA, Ajeel AI, Bahar AJ, Nuaimy AA. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome. Saudi Med J. 2007;28(7):1039-43.

Robinson S, Rodin DA, Deacon A, Wheeler MJ, Clayton RN. Which hormone tests for the diagnosis of polycystic ovary syndrome?, Br J Obstet Gynaecol. 1992;99(3):232-8.

Li X, Lin JF. Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome. Zhonghua Yi Xue Za Zhi. 2005;85(46):3266-71.

Banaszewska B, Spaczynski RZ, Pelesz M, Pawelczyk L. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia. Rocz Akad Med Bialymst. 2003;48:131-4.

Bhattacharya SM, Jha A. Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS). Fertil Steril. 2010;94(1):357-9.

Creatsas G, Deligeoroglou E. Polycystic ovarian syndrome in adolescents. Curr Opin Obstet Gynecol. 2007;19(5):420-6.

Kamboj MK, Bonny AE. Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies. Transl Pediatr. 2017;6(4):248-55.

Hashemipour M, Faghihimani S, Zolfaghary B, Hovsepian S, Ahmadi F, Haghighi S. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Horm Res. 2004;62(6):278-82.

Siklar Z, Oçal G, Adiyaman P, Ergur A, Berberoglu M. Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche. J Pediatr Endocrinol Metab. 2007;20(4):475-81.

Ergur A, Berberoğlu M. Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche. J Pediatr Endocrinol Metab. 2007 Apr; 20(4):475-81.

Buczkowska E, Jarosz CP, Deja G. Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome. Przegl Lek. 2006;63(4):234-8.

Davies MJ, Lord J. Health education on knowledge on polycystic ovarian syndrome. Nursing J India. 2004;276-98.